Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Clinical Trials in the USA / NCT07501299
Recruiting Observational

HeartBeam ECG Registry

NCT07501299 · tracked via the Priya Life Science USA tracker
Sponsor
HeartBeam, Inc
Phase
Observational
Started
2026-03-30
Last updated
2026-07-20

Condition(s) studied

Atrial FibrillationAtrial FlutterBradycardiaTachycardiaArrhythmia

Investigational drug(s) / intervention(s)

Electrocardiogram (ECG)

Electrocardiogram (ECG): The intervention consists of non-invasive ECG recordings obtained using the HeartBeam System. Participants will use the device to capture cardiac electrical activity for assessment of heart rhythm, conduction patterns, and heart rate abnormalities in a clinical setting.

Study summary

The HeartBeam ECG Registry will collect ECG recordings acquired with the HeartBeam System with relevant clinical information in clinical settings.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: 1. Undergoing ECG as part of standard of care. 2. Able and willing to provide written informed consent. Exclusion Criteria: 1. Open chest wounds or surgery to the chest or abdomen within 30 days. 2. Inability to complete ECG acquisition with either HeartBeam device or standard 12-L ECG. 3. Unstable condition where registry participation may interfere with care.

Primary outcome measure(s)

  • Creation of a de-identified ECG dataset for future research and regulatory use — 2 years
    ECG recordings collected during the study will be de-identified and compiled into a database that may be used by HeartBeam for future research and regulatory submissions. The collected data are for observational purposes only and will not be used for clinical decision-making.

Trial sites (1)

FacilityCityRegionStatus
Allegheny Health Network Pittsburgh Pennsylvania Recruiting

Other trials for the same condition

Amplatzer Amulet LAAO vs. NOAC Active, not recruiting
Tracking Results of Ablations to Combat AF Registry Generation 2 Recruiting
Globe Registry: Globe® Pulsed Field System Registry Study for Treating Patients With Symptomatic Atrial Fibrillation Recruiting
PULSED AF Post-Approval Study Recruiting
BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07501299 on ClinicalTrials.gov ↗ ← All trials in the USA